ELARIS EM-COC Endometriosis Study (Click here to learn more)

Do you Have Pain Caused by Endometriosis?

You are not alone.

1 in every 10 women live with endometriosis.

Researchers are evaluating an oral investigation medication to see if it may reduce moderate to severe pain associated with endometriosis in premenopausal women.  The ELARIS EM-COC study is evaluating the safety and effectiveness of an oral investigational medication when taken together with a combined oral contraceptive that contains estrogen and progesterone, in premenopausal women that are experiencing endometriosis pain.  The combined oral contraceptive contains both estrogen and progesterone medication and has been approved by the US FDA as a method of contraception.  The investigational medication has been FDA approved for moderate-to-severe pain associated with endometriosis.  However, the investigational medication is not approved to be used together with a combined oral contraceptive, therefore, the use of the investigational medication combined with the oral contraceptive is investigation (experimental) for the purpose of this study.

You may qualify for the ELARIS EM-COC study if you:

  • Are a premenopausal woman between the ages of 18 and 49
  • Have had a surgical diagnosis of endometriosis
  • Have moderate-to-severe pain from endometriosis
  • Are not pregnant, actively trying to get pregnant or breastfeeding
  • Do not have osteoporosis (thinning, weak bones) or any other bone disease

Eligible participants will receive all study-related care, investigational medication, and non-hormonal birth control supplies (as applicable) at no cost.  In addition, eligible participants may receive compensation for time and travel.  No health insurance is required.

For more information about this study, please call (316) 425-6333.